We are now living in a rapidly evolving therapeutic landscape for inherited neuropathies – one in...

The World Federation of Neurology (WFN) and the Korean Neurological Association hosted the XXVII World Congress...

New Irish research has revealed the first-ever national data on the incidence of sudden unexpected death...

New research presented at ECTRIMS 2024 suggests that initiating monoclonal antibody therapy during childhood, rather than...

 A landmark study has uncovered novel ancestry-specific genetic variants linked to multiple sclerosis (MS), offering new...

A pioneering study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening...

A new study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS),...

Recent developments in the understanding of MS pathogenesis have suggested new avenues for disease-modifying therapy; in...

An overview of the latest insights, diagnostic criteria, and treatment approaches for migraines. Migraine is the...

A new treatment for Parkinson’s disease has recently been made available in Ireland...

In this issue, national and international conference coverage, who to refer for genetic testing for dementia,...

Neurological disorders are currently the second highest cause of death and the leading cause of disability...